Hyman B. Muss

46.8k total citations · 13 hit papers
556 papers, 29.7k citations indexed

About

Hyman B. Muss is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Hyman B. Muss has authored 556 papers receiving a total of 29.7k indexed citations (citations by other indexed papers that have themselves been cited), including 338 papers in Oncology, 154 papers in Cancer Research and 130 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Hyman B. Muss's work include Breast Cancer Treatment Studies (141 papers), Cancer Treatment and Pharmacology (108 papers) and Frailty in Older Adults (103 papers). Hyman B. Muss is often cited by papers focused on Breast Cancer Treatment Studies (141 papers), Cancer Treatment and Pharmacology (108 papers) and Frailty in Older Adults (103 papers). Hyman B. Muss collaborates with scholars based in United States, Israel and Canada. Hyman B. Muss's co-authors include Shlomit Strulov Shachar, Grant R. Williams, Donald A. Berry, Constance Cirrincione, Tomohiro F. Nishijima, Larry Norton, Allison M. Deal, Kirsten A. Nyrop, Clifford A. Hudis and Eric P. Winer and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Hyman B. Muss

540 papers receiving 28.9k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Improved Outcomes From Adding Sequential Paclitaxel but Not From Escalating Doxorubicin Dose in an Adjuvant Chemotherapy Regimen for Patients With Node-Positive Primary Breast Cancer

2003 921 citations Donald A. Berry, Constance Cirrincione et al. Journal of Clinical Oncology profile →
Lumpectomy Plus Tamoxifen With or Without Irradiation in Women Age 70 Years or Older With Early Breast Cancer: Long-Term Follow-Up of CALGB 9343

2013 826 citations Constance Cirrincione, Donald A. Berry et al. Journal of Clinical Oncology profile →
Randomized Trial of Letrozole Following Tamoxifen as Extended Adjuvant Therapy in Receptor-Positive Breast Cancer: Updated Findings from NCIC CTG MA.17

2005 818 citations Hyman B. Muss, Larry Norton et al. profile →
Prognostic value of sarcopenia in adults with solid tumours: A meta-analysis and systematic review

2016 795 citations Shlomit Strulov Shachar, Grant R. Williams et al. European Journal of Cancer profile →
c-erbB-2 Expression and Response to Adjuvant Therapy in Women with Node-Positive Early Breast Cancer

1994 779 citations Hyman B. Muss, Donald A. Berry et al. profile →
Lumpectomy plus Tamoxifen with or without Irradiation in Women 70 Years of Age or Older with Early Breast Cancer

2004 733 citations Donald A. Berry, Constance Cirrincione et al. profile →
Randomized Phase III Trial of Whole-Abdominal Irradiation Versus Doxorubicin and Cisplatin Chemotherapy in Advanced Endometrial Carcinoma: A Gynecologic Oncology Group Study

2005 625 citations Marcus E. Randall, Virginia L. Filiaci et al. Journal of Clinical Oncology profile →
Estrogen-Receptor Status and Outcomes of Modern Chemotherapy for Patients With Node-Positive Breast Cancer

2006 518 citations Donald A. Berry, Constance Cirrincione et al. profile →
Endocrine Therapy for Hormone Receptor–Positive Metastatic Breast Cancer: American Society of Clinical Oncology Guideline

2016 446 citations Hyman B. Muss, Harold J. Burstein et al. Journal of Clinical Oncology profile →
Extending Aromatase-Inhibitor Adjuvant Therapy to 10 Years

2016 411 citations Hyman B. Muss, Eric P. Winer et al. profile →
Validation of a Prediction Tool for Chemotherapy Toxicity in Older Adults With Cancer

2016 402 citations Arti Hurria, Supriya G. Mohile et al. Journal of Clinical Oncology profile →
Cardiopulmonary Function and Age-Related Decline Across the Breast Cancer Survivorship Continuum

2012 322 citations Hyman B. Muss et al. Journal of Clinical Oncology profile →
Older adult participation in cancer clinical trials: A systematic review of barriers and interventions

2020 287 citations Mina S. Sedrak, Rachel A. Freedman et al. profile →

Peers

Countries citing papers authored by Hyman B. Muss

Since Specialization

Citations

This map shows the geographic impact of Hyman B. Muss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hyman B. Muss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hyman B. Muss more than expected).

Fields of papers citing papers by Hyman B. Muss

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hyman B. Muss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hyman B. Muss. The network helps show where Hyman B. Muss may publish in the future.

Co-authorship network of co-authors of Hyman B. Muss

This figure shows the co-authorship network connecting the top 25 collaborators of Hyman B. Muss. A scholar is included among the top collaborators of Hyman B. Muss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hyman B. Muss. Hyman B. Muss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Comparison of patient-reported symptoms with multi-item patient-reported outcome measures of fatigue, anxiety, and depression in the clinical care of women undergoing chemotherapy for early breast cancer 2025 ·Quality of Life Research ·Kirsten A. Nyrop, Allison M. Deal, (unknown), Hyman B. Muss, (unknown)	0
2	Age, Body Mass Index, Tumor Subtype, and Racial and Ethnic Disparities in Breast Cancer Survival 2023 ·JAMA Network Open ·Marla Lipsyc-Sharf, Karla V. Ballman, (unknown), Hyman B. Muss, Edith A. Perez, Lawrence N. Shulman, Lisa A. Carey, Ann H. Partridge, Erica T. Warner	10
3	Survival in Older Japanese Adults With Advanced Cancer Before and After Implementation of a Geriatric Oncology Service 2023 ·JCO Oncology Practice ·Tomohiro F. Nishijima, Mototsugu Shimokawa, Masato Komoda, (unknown), Yuta Okumura, Masaru Morita, Yasushi Toh, Taito Esaki, Hyman B. Muss	7
4	Falls prechemotherapy and toxicity‐related hospitalization during adjuvant chemotherapy for breast cancer in older women: Results from the prospective multicenter HOPE trial 2023 ·Cancer ·Jingran Ji, (unknown), Can‐Lan Sun, Tanya M. Wildes, Rachel A. Freedman, Allison Magnuson, Tracey L. O’Connor, Beverly Moy, Heidi D. Klepin, Andrew E. Chapman, William P. Tew, Efrat Dotan, Mary Anne Fenton, Heeyoung Kim, Vani Katheria, Cary P. Gross, Harvey Jay Cohen, Hyman B. Muss, Mina S. Sedrak	6
5	Inflammation and Clinical Decline After Adjuvant Chemotherapy in Older Adults With Breast Cancer: Results From the Hurria Older Patients Prospective Study 2022 ·Journal of Clinical Oncology ·Jingran Ji, Can‐Lan Sun, Harvey Jay Cohen, Timothy W. Synold, Hyman B. Muss, Mina S. Sedrak	16
6	Risk Factors for Hospitalizations Among Older Adults with Gastrointestinal Cancers 2022 ·The Oncologist ·Daneng Li, Can‐Lan Sun, Rebecca Allen, Christiana Crook, Abrahm Levi, (unknown), Heidi D. Klepin, (unknown), Supriya G. Mohile, William P. Tew, Cynthia Owusu, Hyman B. Muss, Stuart M. Lichtman, Cary P. Gross, Andrew E. Chapman, Ajeet Gajra, Harvey Jay Cohen, Vani Katheria, Arti Hurria, William Dale	3
7	Effects of capecitabine as part of neo-/adjuvant chemotherapy – A meta-analysis of individual breast cancer patient data from 13 randomised trials including 15,993 patients 2022 ·European Journal of Cancer ·Marion van Mackelenbergh, Fenja Seither, Volker Möbus, Joyce O’Shaughnessy, Miguel Martín, Heikki Joensuu, Michael Untch, Ulrike Nitz, Guenther G. Steger, J. Miralles, Carlos H. Barrios, Masakazu Toi, Harry D. Bear, Hyman B. Muss, Toralf Reimer, Valentina Nekljudova, Sibylle Loibl	9
8	Physical Function, Psychosocial Status, and Symptom Burden Among Adults with Plasma Cell Disorders and Associations with Quality of Life 2022 ·The Oncologist ·Christopher E. Jensen, (unknown), Kirsten A. Nyrop, Allison M. Deal, (unknown), Shakira J. Grant, Hyman B. Muss, Eben I. Lichtman, Samuel M. Rubinstein, William A. Wood, (unknown), (unknown), Sascha A. Tuchman	6
9	Person‐centered communication about weight and weight management: Focus group discussions in a diverse sample of women with nonmetastatic breast cancer and obesity 2021 ·Cancer ·Kirsten A. Nyrop, (unknown), Randall Teal, Kathryn E. Stein, Hyman B. Muss, Marjory Charlot	3
10	Patient-reported treatment toxicity and adverse events in Black and White women receiving chemotherapy for early breast cancer 2021 ·Breast Cancer Research and Treatment ·Kirsten A. Nyrop, (unknown), Allison M. Deal, Stephanie B. Wheeler, Marjory Charlot, Bryce B. Reeve, Ethan Basch, Shlomit Strulov Shachar, Lisa A. Carey, Katherine E. Reeder‐Hayes, Elizabeth Claire Dees, Trevor A. Jolly, Gretchen Kimmick, Meghan Karuturi, Raquel E. Reinbolt, (unknown), William A. Wood, Hyman B. Muss	15
11	Is “Geriatric” Assessment Just for Older Patients? 2019 ·The Oncologist ·Gabriel Aleixo, Seul Ki Choi, (unknown), Kirsten A. Nyrop, Allison M. Deal, William A. Wood, Trevor A. Jolly, Hyman B. Muss	13
12	Bioelectrical Impedance Analysis for the Assessment of Sarcopenia in Patients with Cancer: A Systematic Review 2019 ·The Oncologist ·Gabriel Aleixo, Shlomit Strulov Shachar, Kirsten A. Nyrop, Hyman B. Muss, Cláudio L. Battaglini, Grant R. Williams	107
13	Body Composition as a Predictor of Toxicity in Patients Receiving Anthracycline and Taxane–Based Chemotherapy for Early-Stage Breast Cancer 2017 ·Clinical Cancer Research ·Shlomit Strulov Shachar, Allison M. Deal, Marc S. Weinberg, Grant R. Williams, Kirsten A. Nyrop, Karteek Popuri, Seul Ki Choi, Hyman B. Muss	121
14	Comparative “nocebo effects” in older patients enrolled in cancer therapeutic trials: Observations from a 446‐patient cohort 2017 ·Cancer ·Jared C. Foster, Jennifer Le‐Rademacher, Josephine Feliciano, Ajeet Gajra, Drew K. Seisler, Ronald P. DeMatteo, Jacqueline M. Lafky, Arti Hurria, Hyman B. Muss, Harvey Jay Cohen, Aminah Jatoi	5
15	Validation of a Prediction Tool for Chemotherapy Toxicity in Older Adults With Cancer breakdown → 2016 ·Journal of Clinical Oncology ·Arti Hurria, Supriya G. Mohile, Ajeet Gajra, Heidi D. Klepin, Hyman B. Muss, Andrew E. Chapman, Feng Tao, David Smith, Can-Lan Sun, Nienke A. de Glas, Harvey Jay Cohen, Vani Katheria, (unknown), Laura Zavala, Abrahm Levi, Chie Akiba, William P. Tew	402
16	Skeletal Muscle Measures as Predictors of Toxicity, Hospitalization, and Survival in Patients with Metastatic Breast Cancer Receiving Taxane-Based Chemotherapy 2016 ·Clinical Cancer Research ·Shlomit Strulov Shachar, Allison M. Deal, Marc S. Weinberg, Kirsten A. Nyrop, Grant R. Williams, Tomohiro F. Nishijima, (unknown), Hyman B. Muss	215
17	Topical Testosterone for Breast Cancer Patients with Vaginal Atrophy Related to Aromatase Inhibitors: A Phase I/II Study 2011 ·The Oncologist ·Sabrina Witherby, Julia V. Johnson, Laurence M. Demers, Sharon Mount, Benjamin Littenberg, Charles D. MacLean, Marie Wood, Hyman B. Muss	116
18	Adjuvant chemotherapy of breast cancer in the older patient. 2010 ·PubMed ·W. Chris Taylor, Hyman B. Muss	4
19	Randomized Phase III Trial of Weekly Compared With Every-3-Weeks Paclitaxel for Metastatic Breast Cancer, With Trastuzumab for all HER-2 Overexpressors and Random Assignment to Trastuzumab or Not in HER-2 Nonoverexpressors: Final Results of Cancer and Leukemia Group B Protocol 9840 2008 ·Journal of Clinical Oncology ·Andrew D. Seidman, Donald A. Berry, Constance Cirrincione, Lyndsay N. Harris, Hyman B. Muss, P. Kelly Marcom, (unknown), Harold J. Burstein, Diana Lake, Charles L. Shapiro, Peter C. Ungaro, Larry Norton, Eric P. Winer, Clifford A. Hudis	446
20	Randomized Phase III Trial of Whole-Abdominal Irradiation Versus Doxorubicin and Cisplatin Chemotherapy in Advanced Endometrial Carcinoma: A Gynecologic Oncology Group Study breakdown → 2005 ·Journal of Clinical Oncology ·Marcus E. Randall, Virginia L. Filiaci, Hyman B. Muss, Nick M. Spirtos, Robert S. Mannel, Jeffrey Fowler, J.T. Thigpen, J Bénda	625

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact